Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,421 | 3,218 | 3,567 | 4,903 | 5,250 |
| TOTAL | $2,581 | $3,279 | $3,667 | $5,040 | $5,462 |
| Non-Current Assets | |||||
| PPE Net | 136 | 145 | 156 | 164 | 172 |
| Intangibles | 264 | 249 | 239 | 212 | 163 |
| Other Non-Current Assets | 71 | 59 | 62 | 53 | 54 |
| TOTAL | $471 | $453 | $456 | $429 | $390 |
| Total Assets | $3,052 | $3,732 | $4,123 | $5,469 | $5,851 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,353 | 1,902 | 1,630 | 548 | 1,271 |
| Accrued Expenses | N/A | N/A | N/A | 718 | N/A |
| TOTAL | $2,353 | $1,902 | $1,630 | $1,266 | $1,271 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,622 | 3,237 | 2,763 | 0 | 0 |
| TOTAL | $5,622 | $3,237 | $2,763 | $N/A | $N/A |
| Total Liabilities | $7,976 | $5,138 | $4,393 | $1,266 | $1,271 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,829 | 34,551 | 33,751 | 33,751 | 32,151 |
| Common Shares | 348 | 346 | 338 | 338 | 322 |
| Retained earnings | -64,583 | -59,486 | -56,297 | -57,487 | -54,066 |
| Other shareholders' equity | 0 | 0 | -3,000 | 0 | 0 |
| TOTAL | $-4,924 | $-1,407 | $-271 | $4,203 | $4,581 |
| Total Liabilities And Equity | $3,052 | $3,732 | $4,123 | $5,469 | $5,851 |